Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The role of interleukin-6 signaling in nervous tissue.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Neuroprotective Effects of Oligodendrocyte Progenitor Cell Transplantation in Premature Rat Brain following Hypoxic-Ischemic Injury.
Cognitive impairment in Chinese neuromyelitis optica.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Sphingolipids in neuroinflammation.
Atomic view of a toxic amyloid small oligomer.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
The medicalisation of revolt: a sociological analysis of medical cannabis users.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
'Green Mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells.
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis.
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children.
Pages
« first
‹ previous
…
288
289
290
291
292
293
294
295
296
…
next ›
last »